FDA: “FDA orders manufacturers of ADHD drugs to notify patients of cardiovascular adverse events and psychiatric adverse events.”
FDA: “The FDA is offering new warnings regarding suicidal thoughts and behavior in young adults taking antidepressants. “
National ADHD Resource Center: “Medication Management for Adults with ADHD.” ”
National ADHD Resource Center: “Drugs Used in the Treatment of ADHD.” “
Pliszka, S. and the AACAP Study Group, Journal of the American Academy of Child and Adolescent Psychiatry, July 2007.
Medscape: “Once a day Guanfacine approved to treat ADHD. “
UpToDate: “Approach to the Treatment of Attention Deficit Hyperactivity Disorder in Adults,” “Pharmacology of Drugs Used to Treat Attention Deficit Hyperactivity Disorder in Children and Adolescents. “
CHADD: “Medication management”.
Center for Medicaid and Medicare Services: “Stimulants and Associated Drugs: Use in Pediatric Patients”.
National Institutes of Health: “Attention deficit hyperactivity disorder”.
CDC: “Managing ADHD: What You Need to Know. “
Mayo Clinic: “Attention Deficit Hyperactivity Disorder in Adults (ADHD)”, “Attention Deficit Hyperactivity Disorder (ADHD) in Children”, “Clonidine (Oral)”, “Guanfacine (oral route). “
American family physician: “Multimodal treatment of attention deficit hyperactivity disorder in children.” “
BMC Psychiatry: “Adult ADHD and Comorbid Disorders: Clinical Implications of a Dimensional Approach. “
Anxiety & Depression Association of America: “Adult ADHD (Attention Deficit Hyperactivity Disorder).
Psychiatry: “Major depression with ADHD. “